The allocation of risks and benefits of publicly sponsored biomedical research is becoming increasingly skewed toward for-profit entities and against the public interest. A legitimate solution to this imbalance would be to levy compulsory government royalty fees on commercial products made...

Against the background of the scarcity of fossil resources and the reduction of the availability of agricultural land, the emergence of climate change and the growth of the world population, it has become necessary to design sustainable and efficient strategies from the point of view of resource...